Aktuellt
SENASTE
Redeye comments on the Q3 report from Bioservo, where we see improving growth and lower cost levels. We are making minor adjustments to our estimates based on the costs and higher other operating income in the quarter. We reiterate our fair value range of SEK 10 to 28 per share with a Base case of SEK 18 per share.
LÄS MER
